All posts by Simmons Hanly Conroy
By Simmons Hanly Conroy | September 19, 2017
Time is Running Out – Online Registration Closes this Week
As we enter the final stretch of preparations for the 9th Annual Miles for Meso 5k, organizers are excited for participants to experience an event that promises to be one of the… Read More
By Simmons Hanly Conroy | September 13, 2017
National Firefighter Registry Could Be Turning Point for 9/11 Responders with Cancer
As the tragic 9/11 anniversary approaches, we come together as a nation for the 16th time to try to make sense of the worst terrorist attack on United States soil. Even close… Read More
By Simmons Hanly Conroy | September 12, 2017
Miles for Meso 5K Registration Closing Soon — Sign Up Now
Online registration for the 9th Annual Miles for Meso 5K will close on Sept. 22 – only 10 days away. If you’re looking for additional inspiration to sign-up this year, consider running… Read More
By Simmons Hanly Conroy | August 28, 2017
No Asbestos Ban in Place Means Workers Will Keep Dying From Mesothelioma
The use of asbestos in building materials has decreased in the United States during the past several decades due to its worldwide recognition as a deadly carcinogen. At the same time, however,… Read More
By Simmons Hanly Conroy | August 25, 2017
Celebrating Meso Heroes From Coast to Coast
In 2011, Mike Mattmuller was only 29-years-old when an x-ray revealed he had mesothelioma – an often fatal form of cancer caused by asbestos exposure that typically afflicts people twice his age.… Read More
By Simmons Hanly Conroy | August 22, 2017
After $417M Loss, Johnson & Johnson Still Refuses to Acknowledge Suffering of Misinformed Talc Consumers
In the first talc trial to be held before a state jury in California, multinational pharma giant Johnson & Johnson lost $417 million in compensatory and punitive damages to a Los Angeles… Read More
By Simmons Hanly Conroy | August 21, 2017
Mesothelioma and Depression: Coping Strategies for Individuals and Their Families
Nearly 3,000 people are diagnosed with mesothelioma every year, all of whom face uncertain futures that may include chemotherapy, radiation and mounting hospital bills. While many tend to focus on treating the… Read More
By Simmons Hanly Conroy | August 15, 2017
ADAO: The Face of Asbestos Victims and their Fight to Ban Asbestos
Today begins our series of Miles for Meso spotlights. Every week between now and race day on Sept. 30, the Simmons Hanly Conroy blog will feature a survivor, warrior, volunteer or organization… Read More
By Simmons Hanly Conroy | August 10, 2017
Communities Band Together to Fight Opioid Epidemic in Nationwide Lawsuit
At a vital turning point in opioid litigation, law firms like Simmons Hanly Conroy are now casting their net beyond chronic pain patients, whose lawsuits against opioid makers have generated millions in… Read More
By Simmons Hanly Conroy | August 2, 2017
Makers of Blood Pressure Drug Benicar Settle 2,300 Lawsuits in a Federal N.J. Court
Daiichi Sankyo, Inc., a Tokyo-based drug maker worth an estimated $12.4 billion, agreed to settle nearly 2,300 patient lawsuits against its blood pressure medication Benicar® (olmesartan medoxomil) and its sister medications Benicar… Read More
